— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.
— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period
— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year
— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year
— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier
— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue
— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially
— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4
Most Popular
Southwest is looking northside as lockdown restrictions ease
When Warren Buffett dumped airline stocks suffering massive losses three weeks ago, he probably overlooked one key aspect about the industry – that no amount of restrictions will kill people’s
Alibaba (BABA) entering a new phase as China emerges from COVID crisis
Alibaba Group Holding Ltd (NYSE: BABA) is striving to regain strength after falling sharply last week, ahead of fourth-quarter earnings. The positive results failed to impress stakeholders as market sentiment
Chinese exodus from US exchanges not an unlikely scenario
The US is now back in the ring with its nemesis China for the second round. This time, the US administration has wasted no time in delivering a massive blow,
One thought on “Organigram (NASDAQ: OGI) Q4 2019 Earnings Snapshot”
Comments are closed.